List of Inhibikase Therapeutics patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11407747 Compositions and methods for inhibiting kinases	Patent 11407747 was granted and assigned to Inhibikase Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Inhibikase Therapeutics	Inhibikase Therapeutics	United States Patent and Trademark Office	11407747	August 9, 2022
‌ US Patent 10906896 Compositions and methods for inhibiting kinases	Patent 10906896 was granted and assigned to Inhibikase Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Inhibikase Therapeutics	Inhibikase Therapeutics	United States Patent and Trademark Office	10906896	February 2, 2021
‌ US Patent 10344027 Compositions and methods for inhibiting kinases	Patent 10344027 was granted and assigned to Inhibikase Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Inhibikase Therapeutics	Inhibikase Therapeutics	United States Patent and Trademark Office	10344027	July 9, 2019
‌ US Patent 10316031 Compositions and methods for inhibiting kinases	Patent 10316031 was granted and assigned to Inhibikase Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Inhibikase Therapeutics	Inhibikase Therapeutics	United States Patent and Trademark Office	10316031	June 11, 2019
‌ US Patent 9487500 Compounds and compositions thereof	Patent 9487500 was granted and assigned to Inhibikase Therapeutics on November, 2016 by the United States Patent and Trademark Office.		Inhibikase Therapeutics	United States Patent and Trademark Office	9487500	November 8, 2016
‌ US Patent 10118923 Compositions and methods for inhibiting kinases	Patent 10118923 was granted and assigned to Inhibikase Therapeutics on November, 2018 by the United States Patent and Trademark Office.	Inhibikase Therapeutics	Inhibikase Therapeutics	United States Patent and Trademark Office	10118923	November 6, 2018
‌ US Patent 9828370 Compositions and methods for inhibiting kinases	Patent 9828370 was granted and assigned to Inhibikase Therapeutics on November, 2017 by the United States Patent and Trademark Office.	Inhibikase Therapeutics	Inhibikase Therapeutics	United States Patent and Trademark Office	9828370	November 28, 2017
‌ US Patent 9907796 Methods of treating tumoral diseases, or bacterial or viral infections	Patent 9907796 was granted and assigned to Inhibikase Therapeutics on March, 2018 by the United States Patent and Trademark Office.		Inhibikase Therapeutics	United States Patent and Trademark Office	9907796	March 6, 2018